Biomedical Application of Nanoparticles

3.3.7.2 Probiotics -- 3.4 Nanoparticle Use for Therapeutic and Diagnostic Purposes -- 3.4.1 Magnetic Nanoparticles -- 3.4.2 Photosensitizer Nanoparticles -- 3.4.3 Radiolabeled Nanoparticles -- 3.4.4 Bi- and Multimodal Nanoparticles -- 3.4.4.1 MR-Optical Dual-Modality in Vivo Imaging -- 3.4.4.2 MR-PET Dual-Modality in Vivo Imaging -- 3.4.4.3 Other Multimodality Imaging -- References -- Chapter 4: Green Synthesis and Characterization of Semiconductor and Metal Nanoparticles -- 4.1 Introduction -- 4.2 Semiconductor Nanoparticles -- 4.3 Metal Nanoparticles -- 4.4 Green Synthesis of Nanomaterials -- 4.5 Characterization Techniques for Nanoparticles -- 4.5.1 Optical Characterization -- 4.5.1.1 UV-Vis Spectroscopy -- 4.5.1.2 Photoluminescence Spectroscopy -- 4.5.1.3 FT-IR Spectroscopy -- 4.5.1.4 Raman Spectroscopy -- 4.5.2 Morphological Characterization -- 4.5.2.1 X-Ray Diffraction Analysis Studies -- 4.5.2.2 Dynamic Light Scattering Technique (DLS) -- 4.5.2.3 Surface Area Analysis (BET) -- 4.5.2.4 X-Ray Photoelectron Spectroscopy -- 4.5.2.5 Atomic Force Microscope (AFM) -- 4.5.2.6 Scanning Electron Microscope (SEM) -- 4.5.2.7 Transmission Electron Microscope (TEM) -- 4.5.3 Elemental Analysis -- 4.5.3.1 Energy Dispersive X-Ray Spectroscopy (EDX) -- 4.5.3.2 Inductively Coupled Plasma Mass Spectrometry (ICP-MS) -- 4.5.4 Biological Characterization -- 4.5.4.1 In Vitro Analysis -- 4.5.4.2 In Vivo Analysis -- 4.6 Nanoparticles in Various Applications -- 4.7 Conclusions -- References -- Section II : Interaction with Biological Systems -- Chapter 5: The Nanoparticle "Coronome" Is Mainly Explained by InterPro Domains of Proteins -- 5.1 Experimental Design: Nanoparticle, Plasma Incubation, and Elution Method Vary Highly -- 5.2 Proteins Retrieved from Corona Are Frequently Linked in Interactomes -- 5.3 Certain InterPro Domains (IPD) Are More Frequently Retrieved